Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT.

Saved in:
Bibliographic Details
Title: Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT.
Authors: Chiusolo P; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Malagola M; University of Brescia, Adult Bone Marrow Transplant Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Giglio F; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy., Frioni F; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Secreto C; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy., Lessi F; Ematologia Azienda Ospedale Padova, Padova, Italy., D'Amore F; Ematologia Azienda Ospedale Padova, Padova, Italy., Monella IM; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy., Abbenante M; Ospedale Opera Padre Pio-San Giovanni Rotondo, San Giovanni Rotondo, Italy., Marconi G; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Nanni J; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Maggi R; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Mattozzi A; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Giammarco S; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Busca A; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy., Sica S; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. simona.sica@unicatt.it., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2026 Jan; Vol. 61 (1), pp. 101-103. Date of Electronic Publication: 2025 Oct 21.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41120716
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chiusolo+P%22">Chiusolo P</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Malagola+M%22">Malagola M</searchLink>; University of Brescia, Adult Bone Marrow Transplant Unit, ASST Spedali Civili di Brescia, Brescia, Italy.<br /><searchLink fieldCode="AU" term="%22Giglio+F%22">Giglio F</searchLink>; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Frioni+F%22">Frioni F</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Secreto+C%22">Secreto C</searchLink>; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Lessi+F%22">Lessi F</searchLink>; Ematologia Azienda Ospedale Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22D'Amore+F%22">D'Amore F</searchLink>; Ematologia Azienda Ospedale Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Monella+IM%22">Monella IM</searchLink>; IEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Abbenante+M%22">Abbenante M</searchLink>; Ospedale Opera Padre Pio-San Giovanni Rotondo, San Giovanni Rotondo, Italy.<br /><searchLink fieldCode="AU" term="%22Marconi+G%22">Marconi G</searchLink>; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Nanni+J%22">Nanni J</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Maggi+R%22">Maggi R</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Mattozzi+A%22">Mattozzi A</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Giammarco+S%22">Giammarco S</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Busca+A%22">Busca A</searchLink>; Division of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Sica+S%22">Sica S</searchLink>; Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. simona.sica@unicatt.it.<br /><searchLink fieldCode="AU" term="%22Papayannidis+C%22">Papayannidis C</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228702459%22">Bone marrow transplantation</searchLink> [Bone Marrow Transplant] 2026 Jan; Vol. 61 (1), pp. 101-103. <i>Date of Electronic Publication: </i>2025 Oct 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8702459 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5365 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202683369%22">02683369 </searchLink><i>NLM ISO Abbreviation: </i>Bone Marrow Transplant <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41120716
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41409-025-02723-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101
    Titles:
      – TitleFull: Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chiusolo P
      – PersonEntity:
          Name:
            NameFull: Malagola M
      – PersonEntity:
          Name:
            NameFull: Giglio F
      – PersonEntity:
          Name:
            NameFull: Frioni F
      – PersonEntity:
          Name:
            NameFull: Secreto C
      – PersonEntity:
          Name:
            NameFull: Lessi F
      – PersonEntity:
          Name:
            NameFull: D'Amore F
      – PersonEntity:
          Name:
            NameFull: Monella IM
      – PersonEntity:
          Name:
            NameFull: Abbenante M
      – PersonEntity:
          Name:
            NameFull: Marconi G
      – PersonEntity:
          Name:
            NameFull: Nanni J
      – PersonEntity:
          Name:
            NameFull: Maggi R
      – PersonEntity:
          Name:
            NameFull: Mattozzi A
      – PersonEntity:
          Name:
            NameFull: Giammarco S
      – PersonEntity:
          Name:
            NameFull: Busca A
      – PersonEntity:
          Name:
            NameFull: Sica S
      – PersonEntity:
          Name:
            NameFull: Papayannidis C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5365
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Bone marrow transplantation
              Type: main
ResultId 1